Rethinking Angina Treatment: Jed Litwiniuk and Uwe Tigör on Auxilius Pharma’s AUX001 | PharmaShots CXO Talks

Can a once-daily formulation help address treatment challenges in chronic stable angina? In the latest PharmaShots CXO Talks, Jed Litwiniuk, MHA, CEO, Auxilius Pharma, and Uwe Tigör, MD, CMO, Auxilius Pharma, discuss AUX001, a modified-release nicorandil formulation designed to simplify treatment and advance value-added cardiovascular medicines. AUX001: Rethinking Chronic Stable Angina Treatment Auxilius Pharma’s lead…

ByAditya Singh9 hours ago

CXO Talks: Jed Litwiniuk & Uwe Tigör from Auxilius Pharma in a Riveting Dialogue Exchange with PharmaShots

In this fifth episode of our recently launched CXO Talks, we spoke with a distinguished panel of speakers from Auxilius Pharma, Jed Litwiniuk, the CEO, and Uwe Tigör, the CMO of the company. Auxilius Pharma is an emerging specialized pharma company aimed at developing, optimizing, and delivering well-established medications internationally. Jed & Uwe walked memory…

ByAditya SinghNovember 11, 2024

CSAP Management: Uwe P Tigör from Auxilius Pharma in Conversation with PharmaShots

Shots: Chronic Stable Angina Pectoris (CSAP) affects over 11M patients in the US. Often considered as the first manifestation of an underlying coronary disease, there is a dearth of new-age innovative anti-anginal drugs Today at PharmaShots we have Uwe P Tigör, Co-founder and Chief Medical Officer at Auxilius Pharma, shedding light on the positive results…

BySaurabh ChaubeyJune 5, 2024

Rethinking Angina Treatment: Jed Litwiniuk and Uwe Tigör on Auxilius Pharma’s AUX001 | PharmaShots CXO Talks

CXO Talks: Jed Litwiniuk & Uwe Tigör from Auxilius Pharma in a Riveting Dialogue Exchange with PharmaShots

CSAP Management: Uwe P Tigör from Auxilius Pharma in Conversation with PharmaShots

Contact US

FOLLOW US